<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00130481</url>
  </required_header>
  <id_info>
    <org_study_id>576-2004</org_study_id>
    <secondary_id>GCRC M-01 RR 000082</secondary_id>
    <secondary_id>Pfizer 2004-0926</secondary_id>
    <secondary_id>DARE 187</secondary_id>
    <nct_id>NCT00130481</nct_id>
  </id_info>
  <brief_title>Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)</brief_title>
  <official_title>Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if Atorvastatin can improve blood vessel stiffness
      and blood vessel function in children 10-18 years old with Type 1 and Type 2 diabetes.
      Subjects will receive atorvastatin 20mg or placebo daily for 3 months and will then switch
      therapies for the next 3 months.

      Hypothesis: Atorvastatin will improve blood vessel function by decreasing arterial stiffness
      and improving blood flow.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Augmentation Index (arterial stiffness)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>ENDO-PAT (Peripheral Arterial Tone) score (endothelial function)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Low density lipoprotein</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urine microalbumin</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pubertal stage</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index (BMI)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated hemoglobin (HbA1c)</measure>
  </secondary_outcome>
  <enrollment>100</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Type 2 Diabetes Mellitus</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atorvastatin 20 mg daily for 3 months</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM) for more than 1
             year

          -  Age 10-18 years.

        Exclusion Criteria:

          -  Cardiovascular disease (CVD)

          -  Liver disease

          -  Pregnancy

          -  Use of cholesterol or triglyceride lowering drugs

          -  Perceived inability to comply with the study protocol

          -  Endocrinopathy other than diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Haller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Haller MJ, Samyn M, Nichols WW, Brusko T, Wasserfall C, Schwartz RF, Atkinson M, Shuster JJ, Pierce GL, Silverstein JH. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care. 2004 Dec;27(12):2911-7.</citation>
    <PMID>15562206</PMID>
  </reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2005</study_first_submitted>
  <study_first_submitted_qc>August 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2005</study_first_posted>
  <last_update_submitted>March 6, 2012</last_update_submitted>
  <last_update_submitted_qc>March 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Children</keyword>
  <keyword>Adolescents</keyword>
  <keyword>Arterial Compliance</keyword>
  <keyword>Physiology Cardiovascular Endothelium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

